Viewing Study NCT00004480



Ignite Creation Date: 2024-05-05 @ 10:23 AM
Last Modification Date: 2024-10-26 @ 9:04 AM
Study NCT ID: NCT00004480
Status: COMPLETED
Last Update Posted: 2005-06-24
First Post: 1999-10-18

Brief Title: Study of Botulinum Toxin in Patients With Primary Hyperhidrosis
Sponsor: Icahn School of Medicine at Mount Sinai
Organization: Office of Rare Diseases ORD

Study Overview

Official Title: None
Status: COMPLETED
Status Verified Date: 2004-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: OBJECTIVES

I Determine the optimal dose of botulinum toxin necessary to decrease sweating in patients with primary hyperhidrosis
Detailed Description: PROTOCOL OUTLINE

Patients receive injections of botulinum toxin in the clinical trial for 6 months Patients undergo an iodine starch test and a sympathetic skin response test to assess the efficacy of the drug Patients also complete questionnaires to evaluate the amount of sweating

Study Oversight

Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
Secondary ID Type Domain Link
MTS-GCO-98-913NE None None None
ALLERGAN-MTS-GCO-98-913NE None None None